State Street SPDR S&P Health Care Equipment ETF (XHE)
| Assets | $149.27M |
| Expense Ratio | 0.35% |
| PE Ratio | 30.34 |
| Forward PE | 18.47 |
| Shares Out | 1.63M |
| Dividend | $0.02 (0.02%) |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 0.70% |
| Volume | 15,033 |
| Open | 92.78 |
| Previous Close | 93.34 |
| Day's Range | 92.78 - 93.11 |
| 52-Week Low | 76.00 |
| 52-Week High | 97.65 |
| Beta | 0.96 |
| Holdings | 75 |
| Inception Date | Jan 26, 2011 |
About XHE
Fund Home PageThe State Street SPDR S&P Health Care Equipment ETF (XHE) is an exchange-traded fund that mostly invests in health care stocks. The fund tracks an equal-weighted index of U.S. health care equipment and supplies companies. XHE was launched on Jan 26, 2011 and is issued by State Street.
Top 10 Holdings
17.72% of assets| Name | Symbol | Weight |
|---|---|---|
| Alphatec Holdings, Inc. | ATEC | 1.95% |
| Intuitive Surgical, Inc. | ISRG | 1.94% |
| ResMed Inc. | RMD | 1.77% |
| Enovis Corporation | ENOV | 1.75% |
| Haemonetics Corporation | HAE | 1.74% |
| AtriCure, Inc. | ATRC | 1.72% |
| Becton, Dickinson and Company | BDX | 1.72% |
| Stryker Corporation | SYK | 1.72% |
| Beta Bionics, Inc. | BBNX | 1.71% |
| Omnicell, Inc. | OMCL | 1.70% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $0.02173 | Dec 24, 2025 |
| Sep 22, 2025 | $0.02972 | Sep 24, 2025 |
| Jun 23, 2025 | $0.02015 | Jun 25, 2025 |
| Dec 23, 2024 | $0.02516 | Dec 26, 2024 |
| Sep 23, 2024 | $0.00699 | Sep 25, 2024 |
| Dec 18, 2023 | $0.02741 | Dec 21, 2023 |
Performance
XHE had a total return of 14.03% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.54%.
News
Health Care Services and Equipment Stocks Poised for Gains
While most attention in health care has been going to large pharma companies, the charts suggest opportunities in niche subsectors.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Watch a CIO explain where investors can find value in the market amid trade tensions
Chris Zaccarelli, chief investment officer at Independent Advisor Alliance, joins "Squawk Box" to discuss where investors can find value in the markets as they continue to digest the news surrounding ...